There are converging preclinical and clinical evidence that suggests that perturbations in the MAPK/ERK signalling pathway are linked to a group of related neurodevelopmental disorders hallmarked by intellectual disability, including autism [48,50,92]. The gene discussed is MAPK1; the disease is autism.